GLENMARK

Glenmark Life Sciences focuses on APIs and contract manufacturing. Expansion into high-margin CDMO services enhances long-term visibility. While pricing pressure persists in commoditized APIs, diversification into regulated markets supports stability. A solid mid-cap pharma play for patient investors.